Forero G - Search Results

1

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.

Tassorelli C, Nagy K, Pozo-Rosich P, Lanteri-Minet M, Sacco S, Nežádal T, Guo H, De Abreu Ferreira R, Forero G, Trugman JM. Tassorelli C, et al. Among authors: forero g. Lancet Neurol. 2024 Apr;23(4):382-392. doi: 10.1016/S1474-4422(24)00025-5. Epub 2024 Feb 13. Lancet Neurol. 2024. PMID: 38364831 Clinical Trial.

2

Cryo-EM structure of the respiratory syncytial virus RNA polymerase.

Cao D, Gao Y, Roesler C, Rice S, D'Cunha P, Zhuang L, Slack J, Domke M, Antonova A, Romanelli S, Keating S, Forero G, Juneja P, Liang B. Cao D, et al. Among authors: forero g. Nat Commun. 2020 Jan 17;11(1):368. doi: 10.1038/s41467-019-14246-3. Nat Commun. 2020. PMID: 31953395 Free PMC article.

3

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.

4

Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.

Durgam S, Gommoll C, Forero G, Nunez R, Tang X, Mathews M, Sheehan DV. Durgam S, et al. Among authors: forero g. J Clin Psychiatry. 2016 Dec;77(12):1687-1694. doi: 10.4088/JCP.15m09885. J Clin Psychiatry. 2016. PMID: 27232052 Free article. Clinical Trial.

5

Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.

Gommoll C, Forero G, Mathews M, Nunez R, Tang X, Durgam S, Sambunaris A. Gommoll C, et al. Among authors: forero g. Int Clin Psychopharmacol. 2015 Nov;30(6):297-306. doi: 10.1097/YIC.0000000000000096. Int Clin Psychopharmacol. 2015. PMID: 26291335 Free PMC article. Clinical Trial.

6

A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.

Gommoll C, Durgam S, Mathews M, Forero G, Nunez R, Tang X, Thase ME. Gommoll C, et al. Among authors: forero g. Depress Anxiety. 2015 Jun;32(6):451-9. doi: 10.1002/da.22365. Epub 2015 Apr 17. Depress Anxiety. 2015. PMID: 25891440 Free PMC article. Clinical Trial.

7

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.

Shiovitz T, Greenberg WM, Chen C, Forero G, Gommoll CP. Shiovitz T, et al. Among authors: forero g. Innov Clin Neurosci. 2014 Jan;11(1-2):10-22. Innov Clin Neurosci. 2014. PMID: 24653937 Free PMC article.

8

Safety and tolerability of levomilnacipran ER in major depressive disorder: results from an open-label, 48-week extension study.

Mago R, Forero G, Greenberg WM, Gommoll C, Chen C. Mago R, et al. Among authors: forero g. Clin Drug Investig. 2013 Oct;33(10):761-71. doi: 10.1007/s40261-013-0126-5. Clin Drug Investig. 2013. PMID: 23999912 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page